TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Dermo Doc AB
Closing information (x1000 EUR)
Closing information | 2024/12 | 2023/12 | 2022/12 |
Turnover |
113
|
96 | |
Financial expenses |
0
![]() |
0 | |
Earnings before taxes |
23
|
4 | |
EBITDA |
23
|
4 | |
Total assets |
155
|
154 | |
Current assets |
65
|
64 | |
Current liabilities |
13
![]() |
13 | |
Equity capital |
142
|
141 | |
- share capital |
5
|
4 | |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Solvency |
91.6%
![]() |
91.6% | |
Turnover per employee |
113
|
96 | |
Profit as a percentage of turnover |
20.4%
|
4.2% | |
Return on assets (ROA) |
14.8%
|
2.6% | |
Current ratio |
500%
|
492.3% | |
Return on equity (ROE) |
16.2%
|
2.8% | |
Change turnover |
17
|
3 | |
Change turnover % |
-15%
|
18%
|
4% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.